PTJ
TIL icon

Paul Tudor Jones’s Instil Bio TIL Stock Holding History

Paul Tudor Jones’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,193
Closed -$27.3K – 2900
2023
Q3 		$27.3K Hold
3,193
– – ﹤0.01% 2201
2023
Q2 		$35.2K Hold
3,193
– – ﹤0.01% 2335
2023
Q1 		$42K Hold
3,193
– – ﹤0.01% 2292
2022
Q4 		$40K Buy
3,193
+2,506
+365% +$124K ﹤0.01% 2249
2022
Q3 		$67K Sell
687
-2,531
-79% -$290K ﹤0.01% 2174
2022
Q2 		$297K Buy
3,218
+1,375
+75% +$195K 0.01% 1571
2022
Q1 		$396K Buy
+1,843
New +$431K 0.01% 1403

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Paul Tudor Jones's TIL Position: Q4 2023 in Review

Paul Tudor Jones sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 3,193 shares — an estimated $27.3K sold.

Paul Tudor Jones first reported a position in TIL in Q1 2022 and held it in 7 quarters. The position peaked at $396K in Q1 2022. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

  • Paul Tudor Jones reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
  • Paul Tudor Jones sold 3,193 Instil Bio shares in Q4 2023, an estimated $27.3K.
  • Paul Tudor Jones first reported a position in Instil Bio in Q1 2022 and held it in 7 quarters.
  • Paul Tudor Jones's Instil Bio position peaked at $396K in Q1 2022.
  • 30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.